Atrás
28
50
Rango del Día
$188.20
$196.96
Rango de 52 Semanas
$178.26
$274.93
Volumen
168,735
Promedio 50D / 200D
$236.81
/
$224.47
Cierre Anterior
$191.05
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (626 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | 21.3 | 0.4 |
| P/B | 3.4 | 2.9 |
| ROE % | 17.8 | 3.8 |
| Net Margin % | 11.3 | 3.9 |
| Rev Growth 5Y % | 30.7 | 10.0 |
| D/E | 0.4 | 0.2 |
Puntos Clave
Revenue grew 30.74% annually over 5 years — strong growth
Earnings grew 15.82% over the past year
ROE of 17.82% — decent returns on equity
Debt/Equity of 0.36 — conservative balance sheet
Generating 78.98M in free cash flow
Revenue growth is decelerating — 1Y growth trails 5Y average by 11.24%
Crecimiento
Revenue Growth (5Y)
30.74%
Revenue (1Y)19.50%
Earnings (1Y)15.82%
FCF Growth (3Y)60.02%
Calidad
Return on Equity
17.82%
ROIC11.97%
Net Margin11.33%
Op. Margin15.32%
Seguridad
Debt / Equity
0.36
Current Ratio2.68
Interest Coverage9.42
Valoración
P/E Ratio
21.31
P/B Ratio3.43
EV/EBITDA17.22
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 19.50% | Revenue Growth (3Y) | 22.75% |
| Earnings Growth (1Y) | 15.82% | Earnings Growth (3Y) | 23.31% |
| Revenue Growth (5Y) | 30.74% | Earnings Growth (5Y) | 44.00% |
| Profitability | |||
| Revenue (TTM) | 602.80M | Net Income (TTM) | 68.31M |
| ROE | 17.82% | ROA | 10.26% |
| Gross Margin | 28.27% | Operating Margin | 15.32% |
| Net Margin | 11.33% | Free Cash Flow (TTM) | 78.98M |
| ROIC | 11.97% | FCF Growth (3Y) | 60.02% |
| Safety | |||
| Debt / Equity | 0.36 | Current Ratio | 2.68 |
| Interest Coverage | 9.42 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 21.31 | P/B Ratio | 3.43 |
| P/S Ratio | 2.42 | PEG Ratio | 1.63 |
| EV/EBITDA | 17.22 | Dividend Yield | 0.00% |
| Market Cap | 1.46B | Enterprise Value | 1.59B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 602.80M | 504.42M | 400.07M | 353.79M | 206.32M |
| Net Income | 68.31M | 58.98M | 44.92M | 41.79M | 15.89M |
| EPS (Diluted) | 8.77 | 7.58 | 5.83 | 5.45 | 2.09 |
| Gross Profit | 170.41M | 146.69M | 112.23M | 90.26M | 51.11M |
| Operating Income | 92.34M | 80.90M | 57.66M | 55.40M | 21.22M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 665.74M | 629.00M | 404.14M | 378.19M | 334.13M |
| Total Liabilities | 241.86M | 286.24M | 118.05M | 140.65M | 139.69M |
| Shareholders' Equity | 423.88M | 342.76M | 286.09M | 237.55M | 194.45M |
| Total Debt | 154.48M | 206.03M | 46.04M | 68.37M | 84.36M |
| Cash & Equivalents | 20.30M | 13.45M | 5.26M | 4.45M | 11.12M |
| Current Assets | 201.00M | 194.95M | 144.63M | 116.35M | 87.32M |
| Current Liabilities | 74.86M | 76.30M | 58.21M | 55.96M | 38.78M |
Puntuaciones de Estrategias
This stock passed the criteria for 2 strategies
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#857 of 1024
Custom
Balanced Risk
#56 of 148
Actividad Reciente
Entró
Cash Flow Compounder
Mar 24, 2026
Entró
Balanced Risk
Mar 24, 2026